XM does not provide services to residents of the United States of America.
A
A

AuroraCannabis


News

Canopy Growth posts smaller-than-expected core loss as costs drop

Canopy Growth posts smaller-than-expected core loss as costs drop Aug 8 (Reuters) - Canadian pot firm Canopy Growth WEED.TO reported a smaller-than-expected core loss for the first quarter on Friday, helped by lower operating expenses and stronger demand for medical cannabis. Its U.S.-listed shares CGC.O were up 3.3% at $7.15 in premarket trading.
A
C

Aurora Cannabis Inc reports results for the quarter ended in June - Earnings Summary

Aurora Cannabis Inc reports results for the quarter ended in June - Earnings Summary Aurora Cannabis Inc ACB.TO reported quarterly adjusted earnings of 13 cents​​ per share for the quarter ended in June. The lone analyst forecast for the quarter was for a loss of 48 cents per share. Revenue was C$83.44 million​; analysts expected C$78.00 million.
A

U.S. STOCKS Ralph Lauren, Illumina, Disney

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, and cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
C
F
I
T
U
G
L
S
A

Aurora Cannabis rises on strong Q1 results

BUZZ-Aurora Cannabis rises on strong Q1 results ** U.S.-listed shares of pot firm Aurora Cannabis ACB.TO , ACB.O up 11.4% at $6.55 premarket ** Co reports positive first-quarter free cash flow (FCF) of C$6.5 mln vs negative FCF of C$11.7 mln a year ago ** Quarterly revenue was up 11.6% at C$83.4 mln from prior year, beating estimates of C$77.2 mln
A

Pot stocks dip on broader US recession worries

BUZZ-Pot stocks dip on broader US recession worries ** Shares of cannabis firms fall amidst a broader sell-off in the market ** Wall Street's main indexes slumped on fears of the United States tipping into recession following weak economic data last week .N ** Gordon Johnson, CEO and Founder of GLJ Research, said a yen carry-trade was also affectin
U
A
C

Aurora Cannabis And Vectura Fertin Pharma, Inc. Announce Commercial Collaboration

BRIEF-Aurora Cannabis And Vectura Fertin Pharma, Inc. Announce Commercial Collaboration Aug 1 (Reuters) - Aurora Cannabis Inc ACB.TO : AURORA CANNABIS AND VECTURA FERTIN PHARMA, INC. ANNOUNCE COMMERCIAL COLLABORATION Source text for Eikon: ID:nCNWPtxpba Further company coverage: ACB.TO
A

Aurora Receives Expanded Cultivation And Unique Research Licenses For German Facility

BRIEF-Aurora Receives Expanded Cultivation And Unique Research Licenses For German Facility July 25 (Reuters) - Aurora Cannabis Inc ACB.TO : AURORA RECEIVES EXPANDED CULTIVATION AND UNIQUE RESEARCH LICENSES FOR GERMAN FACILITY Source text for Eikon: ID:nCNWT9qW8a Further company coverage: ACB.TO
A

CGI, Empire Company, Kinaxis

CANADA RESEARCH ROUNDUP-CGI, Empire Company, Kinaxis June 21 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies, including CGI, Empire Company and Kinaxis, on Friday. HIGHLIGHTS * Alimentation Couche-Tard ATD.TO : Canaccord Genuity raises PT to C$87 from C$84 * Canadian Natural Resources Ltd CNQ.TO : Wells Fargo cuts PT to C$52 from C$56 * CGI Inc GIBa.TO : CIBC cuts to neutral from outperformer * Empire Company Ltd EMPa.TO : Desjardins raises t
A

U.S. STOCKS Allstate, MicroStrategy, AutoZone

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq hit record highs on Thursday, boosted by strong gains in Nvidia, while investors assessed recent economic data and commentary from Federal Reserve officials to gauge the timing of interest-rate cuts this year.
G
K
M
N
U
U
D
A
D

Aurora Cannabis falls as Q4 revenue misses estimates

BUZZ-Aurora Cannabis falls as Q4 revenue misses estimates ** Shares of Canada's Aurora Cannabis ACB.TO fall 5.95% to C$7.27 ** Posts fiscal Q4 net revenue of C$67.40 mln ($49.19 million), below est. of C$70.50 mln - LSEG data ** Consumer cannabis revenue declines to C$10.20 mln vs. C$14.50 mln a year earlier ** Adj. core profit falls to C$1.90 mln,
A

Stocks up as Swiss cut again, BoE eyed; yuan slides

MORNING BID AMERICAS-Stocks up as Swiss cut again, BoE eyed; yuan slides A look at the day ahead in U.S. and global markets from Mike Dolan Wall Street returns from its midweek break to find record high stocks still chomping at the bit, with overseas monetary easing in focus as the Swiss cut interest rates for the second time this year and the Bank of England decision now awaited.
C
G
K
M
N
T
U
U
J
U
U
F
A
D



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.